Lista de obras - Eran R Andrechek - Dominio Público Uruguay

A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer

artículo científico publicado en 2014

A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer.

artículo científico publicado en 2012

A role for E2F activities in determining the fate of Myc-induced lymphomagenesis

artículo científico publicado en 2009

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

artículo científico publicado en 2000

Anchorage-independent cell growth signature identifies tumors with metastatic potential

artículo científico publicado en 2009

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

artículo científico publicado en 2006

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

artículo científico publicado en 2002

Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion

artículo científico publicado en 2016

Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients

artículo científico publicado en 2015

Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.

artículo científico publicado en 2004

Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia.

artículo científico publicado en 2007

ErbB2 is required for muscle spindle and myoblast cell survival.

artículo científico publicado en 2002

Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy

scientific journal article

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers

scientific article published on 01 August 2003

Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential

scholarly article

Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis

scholarly article

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors.

artículo científico publicado en 2013

Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence

artículo científico publicado en 2011

Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers

artículo científico publicado en 2018

How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective

scientific article published on 21 June 2019

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer

artículo científico publicado en 2014

Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness

artículo científico publicado en 2016

Increased metastasis with loss of E2F2 in Myc-driven tumors

artículo científico publicado en 2015

Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies.

artículo científico publicado en 2010

NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors

artículo científico publicado en 2013

Patterns of cell signaling pathway activation that characterize mammary development.

artículo científico publicado en 2008

Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors

scientific article published on 18 January 2011

Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation

artículo científico publicado en 2014

Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer

artículo científico publicado en 2016

Studying Lymphatic Metastasis in Breast Cancer: Current Models, Strategies, and Clinical Perspectives

artículo científico publicado en 2020

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth

artículo científico publicado en 2005

The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer

artículo científico publicado en 2014

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

artículo científico publicado en 2016

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression

artículo científico publicado en 2014

Transcription factor compensation during mammary gland development in E2F knockout mice.

artículo científico publicado en 2018

Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.

artículo científico publicado en 2000

Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial

artículo científico publicado en 2018

Utilization of genomic signatures to identify phenotype-specific drugs

artículo científico publicado en 2009

Lista de obras de Eran R Andrechek

A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer

A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer.

A role for E2F activities in determining the fate of Myc-induced lymphomagenesis

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

Anchorage-independent cell growth signature identifies tumors with metastatic potential

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion

Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients

Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.

Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia.

ErbB2 is required for muscle spindle and myoblast cell survival.

Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers

Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential

Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors.

Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence

Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers

How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer

Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness

Increased metastasis with loss of E2F2 in Myc-driven tumors

Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies.

NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors

Patterns of cell signaling pathway activation that characterize mammary development.

Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors

Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation

Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer

Studying Lymphatic Metastasis in Breast Cancer: Current Models, Strategies, and Clinical Perspectives

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth

The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression

Transcription factor compensation during mammary gland development in E2F knockout mice.

Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.

Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial

Utilization of genomic signatures to identify phenotype-specific drugs